InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-11-02 00:00:00 ET · period of report 2021-10-25 · accession 0001209191-21-062555 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-02 2021-10-25 WGS Prentice Anthony Chief Product Off S - Sale+OE $8.09 -1,620 2,320 -41% -$13.1K
D 2021-11-02 2021-10-25 WGS Prentice Anthony Chief Product Off M - OptEx — +3,940 3,940 New —
D 2021-11-02 2021-10-25 WGS Prentice Anthony Chief Product Off M - OptEx $0.00 -3,940 59.1K -6% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-10-25 S D 1,620 $8.09 2,320 D — —
2 Common Class A Common Stock 2021-10-25 M A 3,940 — 3,940 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
3 Derivative Restricted Stock Unit 2021-10-25 M D 3,940 $0.00 59,109 D — · — to — 3,940 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.